Vivos Therapeutics, Inc. financial data

Symbol
VVOS on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
7921 Southpark Plaza,, Suite 210, Littleton, CO
State of incorporation
DE
Fiscal year end
December 31
Former names
Vivos BioTechnologies, Inc. (to 9/29/2017)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 54.5 % -45.4%
Debt-to-equity 559 % +239%
Return On Equity -652 % -107%
Return On Assets -99 % +16.9%
Operating Margin -96.2 % +29%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.4M shares -88.6%
Common Stock, Shares, Outstanding 3.4M shares -88.6%
Entity Public Float 15.3M USD -34.1%
Common Stock, Value, Issued 3K USD +50%
Weighted Average Number of Shares Outstanding, Basic 3.23M shares +170%
Weighted Average Number of Shares Outstanding, Diluted 3.23M shares +170%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 14M USD -9.23%
Research and Development Expense 100K USD -50%
Selling and Marketing Expense 2.22M USD -45.9%
General and Administrative Expense 19.1M USD -25%
Operating Income (Loss) -13.5M USD +35.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.93M USD +65.1%
Net Income (Loss) Attributable to Parent -12M USD +35.8%
Earnings Per Share, Basic -7.03 USD/shares +77.8%
Earnings Per Share, Diluted -7.03 USD/shares +77.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.9M USD +75.1%
Accounts Receivable, after Allowance for Credit Loss, Current 395K USD +20.8%
Assets, Current 7.85M USD +47%
Property, Plant and Equipment, Net 3.26M USD -0.25%
Operating Lease, Right-of-Use Asset 1.22M USD -21.2%
Intangible Assets, Net (Excluding Goodwill) 395K USD -11.2%
Goodwill 2.84M USD 0%
Assets 15.8M USD +15.2%
Accounts Payable, Current 2.03M USD +53.1%
Accrued Liabilities, Current 2.19M USD +12.1%
Contract with Customer, Liability, Current 1.8M USD -23.9%
Liabilities, Current 6.64M USD -21.3%
Long-term Debt and Lease Obligation 1.2M USD 0%
Contract with Customer, Liability, Noncurrent 352K USD +33.3%
Operating Lease, Liability, Noncurrent 1.28M USD -27.4%
Liabilities 9.5M USD -18.4%
Retained Earnings (Accumulated Deficit) -98.7M USD -13.9%
Stockholders' Equity Attributable to Parent 6.35M USD +201%
Liabilities and Equity 15.8M USD +15.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.52M USD +28.9%
Net Cash Provided by (Used in) Financing Activities 3.64M USD -50.6%
Net Cash Provided by (Used in) Investing Activities -151K USD +47.8%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 3.4M shares -88.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 968K USD -72.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2K USD -60%
Deferred Tax Assets, Valuation Allowance 19.3M USD +23.6%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 19.7M USD +22.7%
Operating Lease, Liability 1.76M USD -20.2%
Depreciation 600K USD +20%
Payments to Acquire Property, Plant, and Equipment 151K USD -36.8%
Lessee, Operating Lease, Liability, to be Paid 2.05M USD -23.1%
Property, Plant and Equipment, Gross 5.85M USD +9.98%
Operating Lease, Liability, Current 484K USD +8.28%
Lessee, Operating Lease, Liability, to be Paid, Year Two 507K USD -14.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 594K USD -4.35%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 282K USD -37.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 493K USD -2.76%
Deferred Tax Assets, Operating Loss Carryforwards 17.4M USD +25.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 133K USD -73%
Operating Lease, Payments 153K USD
Additional Paid in Capital 105M USD +18.3%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 100K USD 0%
Depreciation, Depletion and Amortization 146K USD -16.6%
Deferred Tax Assets, Net of Valuation Allowance 340K USD -13.7%
Share-based Payment Arrangement, Expense 300K USD -25%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%